Disclaimer:
For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
 
Overview:
BPC-157 and TB-500 are two complementary regenerative peptides extensively studied for their potential to accelerate tissue healing, reduce inflammation, and enhance recovery in preclinical models. When combined, they form a powerful dual formulation that targets both cell migration and angiogenesis, key processes in tissue repair and regeneration.
Mechanism of Action:
BPC-157: A synthetic fragment of the body protection compound derived from gastric proteins, BPC-157 supports cellular repair by promoting angiogenesis, collagen synthesis, and fibroblast activity. It also modulates nitric oxide pathways to enhance blood flow and reduce inflammation.
TB-500 (Thymosin Beta-4): A naturally occurring peptide that regulates actin cytoskeleton organization, TB-500 aids in cell migration and differentiation. It has been shown to promote wound closure, muscle regeneration, and recovery from soft-tissue injury in preclinical research.
Together, these peptides are studied for their synergistic effects on recovery and regeneration, with each enhancing the other’s activity in tissue remodeling and healing responses.
Research Highlights:
Demonstrated accelerated healing of muscle, tendon, and ligament injuries in preclinical models.
Shown to reduce inflammation and fibrosis while improving vascularization.
Studied for applications in tissue regeneration, angiogenesis, and recovery optimization.
Represents a leading peptide combination in regenerative and recovery-based research studies.
Specifications:
Form: Lyophilized powder (research-grade)
Purity: ≥99% (HPLC-tested)
Storage: Store refrigerated (2–8 °C), away from light and moisture.